EMERGENT BIOSOLUTIONS INC. Income Taxes Paid
EMERGENT BIOSOLUTIONS INC. (EBS) reported Income Taxes Paid of $9.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. income taxes paid for the quarter ending 2026-06-30 was $4.30M, a 104.76% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for the quarter ending 2026-03-31 was $5.30M, a 63.45% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for the quarter ending 2025-12-31 was $12.50M.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for the quarter ending 2025-09-30 was $10.90M, a 13.54% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for fiscal 2025 was $40.00M, a 50.94% increase from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for fiscal 2024 was $26.50M, a 49.81% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for fiscal 2023 was $52.80M, a 751.61% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. income taxes paid for fiscal 2022 was $6.20M, a 91.34% decline from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.60M 10-Q · filed 2026-08-06 | $22.10M derived: sum of 3 quarters · filed 2026-08-06 | $33.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $5.30M 10-Q · filed 2026-05-01 | $17.80M derived: sum of 2 quarters · filed 2026-05-01 | $28.70M derived: sum of 3 quarters · filed 2026-05-01 | $30.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.40M derived: sum of 2 quarters · filed 2026-02-27 | $25.50M derived: sum of 3 quarters · filed 2026-08-06 | $40.00M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $13.00M derived: sum of 2 quarters · filed 2026-08-06 | $27.50M 10-Q · filed 2025-10-30 | $18.50M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.60M 10-Q · filed 2026-08-06 | $7.60M derived: sum of 3 quarters · filed 2026-08-06 | $17.20M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $14.50M 10-Q · filed 2026-05-01 | $5.50M derived: sum of 2 quarters · filed 2026-05-01 | $15.10M derived: sum of 3 quarters · filed 2026-05-01 | $28.60M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $600.00K derived: sum of 2 quarters · filed 2026-02-27 | $14.10M derived: sum of 3 quarters · filed 2026-02-27 | $26.50M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $23.10M derived: sum of 2 quarters · filed 2025-10-30 | $35.50M 10-Q · filed 2025-10-30 | $50.00M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $25.90M 10-Q · filed 2025-08-07 | $40.40M derived: sum of 3 quarters · filed 2026-02-27 | $51.80M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $12.40M 10-Q · filed 2025-05-08 | $26.90M derived: sum of 2 quarters · filed 2026-02-27 | $38.30M derived: sum of 3 quarters · filed 2026-02-27 | $48.50M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $14.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.90M derived: sum of 2 quarters · filed 2026-02-27 | $36.10M derived: sum of 3 quarters · filed 2026-02-27 | $52.80M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $21.60M derived: sum of 2 quarters · filed 2024-11-07 | $38.30M 10-Q · filed 2024-11-07 | $20.60M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $26.90M 10-Q · filed 2024-08-07 | $9.20M derived: sum of 3 quarters · filed 2025-03-04 | $13.10M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-03-31 | $16.70M 10-Q · filed 2024-05-02 | -$1.00M derived: sum of 2 quarters · filed 2025-03-04 | $2.90M derived: sum of 3 quarters · filed 2025-03-04 | $18.10M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2022-12-31 | -$17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$13.80M derived: sum of 2 quarters · filed 2025-03-04 | $1.40M derived: sum of 3 quarters · filed 2025-03-04 | $6.20M 10-K · filed 2025-03-04 | |
| 2022-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | $19.10M derived: sum of 2 quarters · filed 2023-12-11 | $23.90M 10-Q · filed 2023-12-11 | $37.90M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-06-30 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $20.00M 10-Q · filed 2023-08-09 | $34.00M derived: sum of 3 quarters · filed 2024-03-08 | $41.30M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-03-31 | $4.80M 10-Q · filed 2023-05-10 | $18.80M derived: sum of 2 quarters · filed 2024-03-08 | $26.10M derived: sum of 3 quarters · filed 2024-03-08 | $74.90M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2021-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $21.30M derived: sum of 2 quarters · filed 2024-03-08 | $70.10M derived: sum of 3 quarters · filed 2024-03-08 | $71.60M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $56.10M derived: sum of 2 quarters · filed 2022-11-09 | $57.60M 10-Q · filed 2022-11-09 | $79.60M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-06-30 | $48.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $50.30M 10-Q · filed 2022-08-02 | $72.30M derived: sum of 3 quarters · filed 2023-12-11 | $147.40M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-03-31 | $1.50M 10-Q · filed 2022-04-29 | $23.50M derived: sum of 2 quarters · filed 2023-12-11 | $98.60M derived: sum of 3 quarters · filed 2023-12-11 | $107.20M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2020-12-31 | $22.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $97.10M derived: sum of 2 quarters · filed 2023-12-11 | $105.70M derived: sum of 3 quarters · filed 2023-12-11 | $109.30M 10-K/A · filed 2023-12-11 | |
| 2020-09-30 | $75.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $83.70M derived: sum of 2 quarters · filed 2021-11-05 | $87.30M 10-Q · filed 2021-11-05 | $96.90M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $12.20M 10-Q · filed 2021-07-30 | $21.80M derived: sum of 3 quarters · filed 2022-02-25 | $29.60M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $3.60M 10-Q · filed 2021-04-30 | $13.20M derived: sum of 2 quarters · filed 2022-02-25 | $21.00M derived: sum of 3 quarters · filed 2022-02-25 | $29.40M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $17.40M derived: sum of 2 quarters · filed 2022-02-25 | $25.80M derived: sum of 3 quarters · filed 2022-02-25 | $30.80M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $16.20M derived: sum of 2 quarters · filed 2020-11-06 | $21.20M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $13.40M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $5.00M 10-Q · filed 2020-05-01 | ||||
| 2018-12-31 | $14.00M 10-K · filed 2021-02-19 | ||||
| 2017-12-31 | $12.00M 10-K · filed 2020-02-25 | $11.98M 10-K · filed 2018-02-23 | |||
| 2016-12-31 | $10.10M 10-K · filed 2019-02-22 | $10.08M 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $28.27M 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | $4.71M 10-K · filed 2017-02-28 | ||||
| 2013-12-31 | $6.33M 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | $6.54M 10-K · filed 2015-03-09 | ||||
| 2011-12-31 | $4.28M 10-K · filed 2014-03-10 | ||||
| 2010-12-31 | $22.44M 10-K · filed 2013-03-08 | ||||
| 2009-12-31 | $15.15M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |